General
Preferred name
THEODRENALINE
Synonyms
(¡À)?-?Theodrenaline ()
Theodrenaline hydrochloride(13460-98-5 Free base) ()
(??)?-?Theodrenaline ()
Theodrenaline (hydrochloride) ()
(±)?-?Theodrenaline (hydrochloride) ()
Theodrenaline hydrochloride ()
Teodrenalina ()
Noradrenaline theophylline ()
(¡À)?-?Theodrenaline (hydrochloride) ()
P&D ID
PD072745
CAS
13460-98-5
2572-61-4
Tags
available
drug
Drug Status
approved
investigational
Max Phase
2.0
Drug indication
Cardiovascular disease
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Theodrenaline hydrochloride is a cardiac stimulant, also acts as an anti-hypotensive agent together with Cafedrine.
PRICE
558
DESCRIPTION
Theodrenaline hydrochloride is an inhibitor targeting SARS-CoV-2 for the study of hypotension induced by spinal anesthesia.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
8
ChEMBL Drugs
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
MedChem Express Bioactive Compound Library
ReFrame library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
25
Molecular Weight
375.15
Hydrogen Bond Acceptors
10
Hydrogen Bond Donors
4
Rotatable Bonds
6
Ring Count
3
Aromatic Ring Count
3
cLogP
-0.83
TPSA
134.54
Fraction CSP3
0.35
Chiral centers
1.0
Largest ring
6.0
QED
0.33
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Metabolic Enzyme/Protease
Microbiology/virology
Target
Phosphodiesterase (PDE)
SARS-CoV-2
Source data

